Targeting eNOS in Pancreatic Cancer

Mortality from pancreatic ductal adenocarcinoma cancer (PDAC) is among the highest of any cancer and frontline therapy has changed little in years. Activation of endothelial nitric oxide synthase (eNOS or NOS III) has been implicated recently in the pathogenesis of PDAC. In this study, we used genet...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lampson, Benjamin L., Kendall, S. DiSean, Ancrile, Brooke B., Morrison, Meghan M., Shealy, Michael J., Barrientos, Katharine S., Crowe, Matthew S., Kashatus, David F., White, Rebekah R., Gurley, Susan B., Cardona, Diana M., Counter, Christopher M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3749841/
https://ncbi.nlm.nih.gov/pubmed/22738914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-12-0057
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi